FDA Enforcement Class II Terminated

Naso-Pharyngo-Laryngoscope Intended to provide optical visualization of, therapeutic access to, the Upper Airway. This anatomy includes, but is not restricted to, the organs, tissues and subsystems: Ear, Nasal Passage and Trachea. The instrument is introduced via the mouth or the nose, as decided by the physician, when indications consistent with the need for procedure are observed in adult and pediatric patient populations

Recall: Z-2074-2016 · Reported July 6, 2016

Enforcement

Recall Number
Z-2074-2016
Event ID
73894
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Pentax Medical Company
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
July 6, 2016
Initiation Date
April 6, 2016
Classification Date
June 28, 2016
Termination Date
December 21, 2017
Address
3 Paragon Dr, Montvale, NJ, 07645-1782, United States

Description

Naso-Pharyngo-Laryngoscope Intended to provide optical visualization of, therapeutic access to, the Upper Airway. This anatomy includes, but is not restricted to, the organs, tissues and subsystems: Ear, Nasal Passage and Trachea. The instrument is introduced via the mouth or the nose, as decided by the physician, when indications consistent with the need for procedure are observed in adult and pediatric patient populations

Reason

Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.

Code Info

Model #'s FNL-10RAP, FNL-13RAP, FNL-15RP3 and VNL-1530T

Distribution

Worldwide Distribution - US (Nation Wide) including Puerto Rico and Internationally to Denmark, Guam

Quantity

215 units